How Should "CRISPRed" Babies Be Monitored Over Their Life Course to Promote Health Equity?

AMA J Ethics. 2019 Dec 1;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.

Abstract

Gene-edited babies who might be born in the future should be monitored over the course of their life. These patients' physical, mental, and social health monitoring should be coordinated by clinicians in ways that anonymize patients' data for privacy protection but also allow for national and international aggregate evaluations. Transnational monitoring efforts should focus on safety and efficacy, social and disability justice, what constitutes the standard of care, and how best to promote both access to care and social and genomic research and innovation. In addition, effective and binding mechanisms for stopping or limiting uses of gene editing technology should be developed.

MeSH terms

  • CRISPR-Cas Systems*
  • Gene Editing* / methods
  • Health Equity / ethics*
  • Humans